13 September 2017

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that on 12 September 2017 it granted options over a total of 1,440,000 ordinary shares of 0.2p each in the Company ("Ordinary Shares") to employees and Directors, of which 1,100,000 options were granted to Directors and PDMRs as detailed below.

Director Number of options granted Exercise price Exercise period Total number of options held following notification Total number of Ordinary Shares held
           
J H Barder 250,000 30.5p 1 Oct 2019 - 30 Sep 2024 1,750,000 1,528,830
           
D A Martin 200,000 30.5p 1 Oct 2019 - 30 Sep 2024 1,060,000 280,000
           
K W James 200,000 30.5p 1 Oct 2019 - 30 Sep 2024 400,000 13,787

 

PDMR Number of options granted Exercise price Exercise period Total number of options held following notification Total number of Ordinary Shares held
           
T Holland 150,000 30.5p 1 Oct 2019 - 30 Sep 2024 917,500 -
           
I Armstrong 150,000 30.5p 1 Oct 2019 - 30 Sep 2024 550,000 -
           
R Hawken 150,000 30.5p 1 Oct 2019 - 30 Sep 2024 150,000 -
           

The 650,000 options granted to: J Barder, D Martin and T Holland were granted under the Futura Medical plc Unapproved Share Option Scheme.

The 450,000 options granted to: K James, I Armstrong and R Hawken and the 340,000 options granted to other employees were granted under the Futura Medical plc Enterprise Management Incentive Scheme.

The main vesting condition of the options is that the Director/PDMR/employee remains employed with the Company as at the date of exercise.

 

 

For further information please contact:

Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com

Nominated Adviser:
N+1 Singer
Aubrey Powell / Liz Yong / Thomas Smale
Tel: +44 (0) 20 7496 3000

For media enquiries please contact:

Buchanan Communications Limited
Mark Court / Sophie Cowles /
Stephanie Watson
Tel: +44 (0) 20 7466 5000

 

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name James Barder
2 Reason for the notification
a) Position/status Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Futura Medical plc
b) LEI 21380053QLT46UNV2303
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 0.2p each GB0033278473
b) Nature of the transactions Issue of options over Ordinary Shares
c) Prices and volumes
Price(s) Volume(s)
30.5 pence 250,000
d) Aggregated information - Aggregated volume - Price Not applicable
e) Date of the transactions 12 September 2017
f) Place of the transactions Outside a trading venue

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Derek Martin
2 Reason for the notification
a) Position/status Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Futura Medical plc
b) LEI 21380053QLT46UNV2303
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 0.2p each GB0033278473
b) Nature of the transactions Issue of options over Ordinary Shares
c) Prices and volumes
Price(s) Volume(s)
30.5 pence 200,000
d) Aggregated information - Aggregated volume - Price Not applicable
e) Date of the transactions 12 September 2017
f) Place of the transactions Outside a trading venue

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Ken James
2 Reason for the notification
a) Position/status Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Futura Medical plc
b) LEI 21380053QLT46UNV2303
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 0.2p each GB0033278473
b) Nature of the transactions Issue of options over Ordinary Shares
c) Prices and volumes
Price(s) Volume(s)
30.5 pence 200,000
d) Aggregated information - Aggregated volume - Price Not applicable
e) Date of the transactions 12 September 2017
f) Place of the transactions Outside a trading venue

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Tim Holland
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Futura Medical plc
b) LEI 21380053QLT46UNV2303
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 0.2p each GB0033278473
b) Nature of the transactions Issue of options over Ordinary Shares
c) Prices and volumes
Price(s) Volume(s)
30.5 pence 150,000
d) Aggregated information - Aggregated volume - Price Not applicable
e) Date of the transactions 12 September 2017
f) Place of the transactions Outside a trading venue

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Ian Armstrong
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Futura Medical plc
b) LEI 21380053QLT46UNV2303
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 0.2p each GB0033278473
b) Nature of the transactions Issue of options over Ordinary Shares
c) Prices and volumes
Price(s) Volume(s)
30.5 pence 150,000
d) Aggregated information - Aggregated volume - Price Not applicable
e) Date of the transactions 12 September 2017
f) Place of the transactions Outside a trading venue

 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Rachael Hawken
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Futura Medical plc
b) LEI 21380053QLT46UNV2303
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 0.2p each GB0033278473
b) Nature of the transactions Issue of options over Ordinary Shares
c) Prices and volumes
Price(s) Volume(s)
30.5 pence 150,000
d) Aggregated information - Aggregated volume - Price Not applicable
e) Date of the transactions 12 September 2017
f) Place of the transactions Outside a trading venue